Bellicum Pharmaceuticals, Inc. is a clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases. Bellicum's novel approach is to utilize precise knowledge of the signaling pathways that regulate the immune response to target specific factors that can influence the potency and duration of this response. Our lead product, BP-GMAX-CD1, is in Phase I clinical trials.
|
|
|
|
|
1-10 employees
View all Bellicum Pharmaceuticals employees
|
|
|
IT Services and IT Consulting
|
|
|
(832) 384-1100
|
|
|
Houston, Texas
|
|
|
July
|
The decision makers in Bellicum Pharmaceuticals are Daisy Lan, etc. Click to Find Bellicum Pharmaceuticals decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.